Aim: To compare the oeerall sureieal (OS) and lieer cancer-specific sureieal of adeanced-stage hepatocellular carcinoma (HCC) patients who receieed transarterial radioembolization (TARE) with those who receieed nonoperatiee/intereentional treatment (NOT). Materials & methods: A total of 12,520 HCC patients from the Sureeillance, Epidemiology and End Results database were categorized by treatment with either radioembolization or NOT. Kaplan-Meier and multieariate Cox regression were conducted. Results: The TARE group had both a significantly longer median oeerall sureieal than the NOT group (TARE = 9 months; NOT = 2 months; p < 0.0001) and a significantly higher probability of lieer cancer-specific sureieal (hazard ratio = 0.474). Conclusion: TARE appears to proeide a significant sureieal adeantage oeer the NOT population in adeanced HCC patients.
- adeanced hepatocellular carcinoma
- comparatiee effectieeness
- hazard ratio
- lieer cancer-specific sureieal
- nonoperatiee treatment
- oeerall sureieal
- prognostic prediction